Global Losartan
Market Report
2025
Losartan Market Report 2025 (Global Edition)
The global Losartan market size will be USD 1625.5 million in 2024. Rising Global Healthcare Infrastructure Expansion is expected to boost sales to USD 2212.1 million by 2031, with a Compound Annual Growth Rate (CAGR) of 4.50% from 2024 to 2031.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Losartan Market Report 2025.
Global Losartan Market Report 2025 Market Size Split by Dosage Form (Tablet, Powder, Suspension), by Application (Hypertension, Stroke, Diabetic Nephropathy, Others), by Distribution Channel (Contract...
According to Cognitive Market Research, the global Losartan market size will be USD 1625.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.
- North America held the major market share for more than 40% of the global revenue with a market size of USD 650.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
- Europe accounted for a market share of over 30% of the global revenue with a market size of USD 487.65 million.
- Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 373.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
- Latin America had a market share of more than 5% of the global revenue with a market size of USD 81.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
- Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 32.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
- The Contract Manufacturing category is the fastest growing segment of the Losartan industry
| 2024 | 2025 | 2032 | 2033 | CAGR | |
|---|---|---|---|---|---|
| Global Losartan Market Sales Revenue | $ 1625.5 Million | 121212 | 121212 | 121212 | 4.5% |
| North America Losartan Market Sales Revenue | $ 650.2 Million | 121212 | 121212 | 121212 | 2.7% |
| Mexico Losartan Market Sales Revenue | $ 59.17 Million | 121212 | 121212 | 121212 | 3.2% |
| Canada Losartan Market Sales Revenue | $ 78.02 Million | 121212 | 121212 | 121212 | 3.5% |
| United States Losartan Market Sales Revenue | $ 513.01 Million | 121212 | 121212 | 121212 | 2.5% |
| Europe Losartan Market Sales Revenue | $ 487.65 Million | 121212 | 121212 | 121212 | 3% |
| Germany Losartan Market Sales Revenue | $ 96.55 Million | 121212 | 121212 | 121212 | 3.2% |
| France Losartan Market Sales Revenue | $ 44.86 Million | 121212 | 121212 | 121212 | 2.2% |
| Spain Losartan Market Sales Revenue | $ 39.99 Million | 121212 | 121212 | 121212 | 2.1% |
| United Kingdom Losartan Market Sales Revenue | $ 81.93 Million | 121212 | 121212 | 121212 | 3.8% |
| Russia Losartan Market Sales Revenue | $ 75.59 Million | 121212 | 121212 | 121212 | 2% |
| Italy Losartan Market Sales Revenue | $ 41.94 Million | 121212 | 121212 | 121212 | 2.4% |
| Rest of Europe Losartan Market Sales Revenue | $ 75.59 Million | 121212 | 121212 | 121212 | 1.7% |
| Asia Pacific Losartan Market Sales Revenue | $ 373.87 Million | 121212 | 121212 | 121212 | 6.5% |
| India Losartan Market Sales Revenue | $ 44.86 Million | 121212 | 121212 | 121212 | 8.3% |
| Korea Losartan Market Sales Revenue | $ 37.39 Million | 121212 | 121212 | 121212 | 5.6% |
| Japan Losartan Market Sales Revenue | $ 51.59 Million | 121212 | 121212 | 121212 | 5% |
| China Losartan Market Sales Revenue | $ 168.24 Million | 121212 | 121212 | 121212 | 6% |
| Australia Losartan Market Sales Revenue | $ 19.44 Million | 121212 | 121212 | 121212 | 6.2% |
| Rest of APAC Losartan Market Sales Revenue | $ 26.54 Million | 121212 | 121212 | 121212 | 6.3% |
| South America Losartan Market Sales Revenue | $ 81.28 Million | 121212 | 121212 | 121212 | 3.9% |
| Peru Losartan Market Sales Revenue | $ 6.66 Million | 121212 | 121212 | 121212 | 4.1% |
| Colombia Losartan Market Sales Revenue | $ 7.23 Million | 121212 | 121212 | 121212 | 3.7% |
| Argentina Losartan Market Sales Revenue | $ 13.65 Million | 121212 | 121212 | 121212 | 4.8% |
| Brazil Losartan Market Sales Revenue | $ 34.79 Million | 121212 | 121212 | 121212 | 4.5% |
| Chile Losartan Market Sales Revenue | $ 5.85 Million | 121212 | 121212 | 121212 | 4.2% |
| Rest of South America Losartan Market Sales Revenue | $ 13.09 Million | 121212 | 121212 | 121212 | 3% |
| Middle East Losartan Market Sales Revenue | $ 32.51 Million | 121212 | 121212 | 121212 | 4.2% |
| Turkey Losartan Market Sales Revenue | $ 2.8 Million | 121212 | 121212 | 121212 | 3.7% |
| Egypt Losartan Market Sales Revenue | $ 3.41 Million | 121212 | 121212 | 121212 | 4.5% |
| Rest of MEA Losartan Market Sales Revenue | $ 3.84 Million | 121212 | 121212 | 121212 | 3.2% |
| Base Year | 2024 |
| Historical Data Time Period | 2021-2024 |
| Forecast Period | 2025-2033 |
| Market Split by Dosage Form |
|
| Market Split by Application |
|
| Market Split by Distribution Channel |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
Report scope is customizable as we have a huge database of Losartan industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Losartan Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Losartan Market Report Description
Introduction of the Losartan Market
Losartan is an angiotensin II receptor blocker (ARB) that is primarily employed to manage hypertension (high blood pressure). It operates by relaxing blood vessels, which facilitates the flow of blood and contributes to the reduction of blood pressure. Losartan is also prescribed to mitigate the risk of stroke in patients with hypertension and left ventricular hypertrophy, as well as to address kidney complications in individuals with diabetes. It is available in oral tablet form and is marketed under brand names such as Cozaar, as well as in generic versions. It is anticipated that the global losartan market will expand rapidly. The global rise in the incidence of hypertension, stroke, and diabetic nephropathy is stimulating the market. The demand for losartan is further fueled by the increasing awareness of cardiovascular health and the ageing population.
In September 2023, Granules India Limited has announced that the US FDA has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, in a variety of dosages. These tablets are bioequivalent to the reference drug, Hyzaar, and are prescribed for the treatment of hypertension and the mitigation of stroke risk in patients with hypertension and left ventricular hypertrophy. Granules India has now received a total of 60 ANDA approvals from the US FDA as a result of this approval. The current annual market for these tablets in the United States is approximately $73 million. (Source: https://granulesindia.com/wp-content/uploads/2023/10/Press-Release-Losartan-HCTZ-Tabs-PR.pdf)
Losartan Market Size
Market Dynamics of Losartan Market
Key Drivers for Losartan Market
The Growing Senior Population to Boost Market Growth
A substantial factor contributing to the losartan market is the increasing geriatric population. The prevalence of age-related health issues, such as frailty and hypertension, is on the rise as the global population ages. Adverse health outcomes, including falls, functional decline, and early mortality, are particularly prevalent among prefrail older adults. Studies conducted by UTHealth Houston have demonstrated that losartan not only assists in the regulation of blood pressure but also enhances physical function and decreases frailty scores in older adults. These advantages render losartan an indispensable medication for elderly patients, resulting in an elevated demand. The market for losartan is anticipated to expand in tandem with the increasing number of prefrail and elderly individuals, as it has been demonstrated to improve the quality of life for this demographic.
Increasing Prevalence of Hypertension to Drive Market Growth
High blood pressure, or hypertension, is a prevalent condition that substantially elevates the likelihood of stroke, heart disease, and other potential health complications. According to the World Health Organization, hypertension is a condition that affects 1.3 billion individuals worldwide, and it is anticipated that this number will double in the years ahead. Losartan, a medication that assists in the reduction of blood pressure by relaxing blood vessels, is essential for the management of hypertension. It is particularly effective in reducing the risk of stroke in patients with left ventricular hypertrophy by inhibiting angiotensin II-induced cardiac remodelling. Losartan has been demonstrated to achieve blood pressure control in 50% of patients after 12 weeks of treatment, according to research. The demand for losartan is a critical component of hypertension management due to the growing prevalence of hypertension and the need to address this widespread health issue.
Restraint Factor for the Losartan Market
Tolerability and Side Effects will Limit Market Growth
Losartan's demand and usage may be substantially impeded by its tolerability and side effects in certain populations. Although the drug is generally well-tolerated, certain patients may experience adverse effects, including fatigue, headache, dizziness, and gastrointestinal tract issues. Discontinuation or reluctance to use the medication may result from these side effects. Tolerability is significantly different among individuals, as factors such as age, underlying medical conditions, and concurrent medications influence it. For example, individuals who are older or have multiple health conditions may be more susceptible to adverse effects. In order to resolve these issues, it is imperative to implement personalized treatment plans and provide patient education. In order to guarantee optimal patient outcomes, healthcare providers must communicate effectively with patients regarding potential side effects and adjust dosages or switch medications as needed. Its side effects and variable tolerability significantly impede Losartan's widespread adoption despite its efficacy.
Impact of Covid-19 on the Losartan Market
The COVID-19 pandemic significantly impacted the losartan market in various ways. Initially, global supply chain disruptions led to shortages and delays in the production and distribution of losartan due to lockdowns and restrictions, especially affecting key manufacturing hubs. This caused temporary supply gaps and challenged the availability of the medication. However, the pandemic also highlighted the importance of cardiovascular health, as individuals with pre-existing conditions such as hypertension were at a higher risk of severe COVID-19 complications. This increased awareness drove a higher demand for antihypertensive medications like losartan. Healthcare systems worldwide prioritized the management of chronic diseases, including hypertension, during the pandemic. This focus helped sustain the demand for losartan despite the supply chain challenges. Additionally, efforts were made to ensure that patients with chronic conditions continued to receive their medications without interruption. The heightened focus on cardiovascular health and the continuous need for effective hypertension management somewhat offset the adverse effects of the initial supply disruptions, maintaining a steady demand for losartan throughout the pandemic.
We have various report editions of Losartan Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Losartan Market Insights Video
Competitive Landscape of the Losartan Market
In the Losartan market's competitive landscape, numerous key competitors are driving innovation and growth. Market rivalry is encouraging technological and design innovations to create Losartans that fulfil both consumer's wants and sustainability goals, keeping the market dynamic and competitive.
In June 2023, Merck completed the acquisition of Prometheus Biosciences, Inc. for an estimated $10.8 billion. This acquisition has significantly improved Merck's immunology pipeline by incorporating Prometheus' leading candidate, PRA-023 (MK-7240), a monoclonal antibody that is intended to treat ulcerative colitis, Crohn's disease, and other autoimmune conditions. This acquisition enhances Merck's research capabilities and fortifies its immunology position. Merck's 2023 GAAP and non-GAAP results will be significantly impacted by a charge of approximately $10.3 billion due to the deal. This acquisition is consistent with Merck's objective to enhance the treatment of immune-mediated diseases and provide patients with value. (Source: https://www.merck.com/news/merck-completes-acquisition-of-prometheus-biosciences-inc/) In June 2023, Deciding to acquire Chinook Therapeutics, a clinical-stage biopharmaceutical company, for a maximum of USD 3.5 billion, Novartis disclosed an agreement. This agreement comprises an initial payment of USD 3.2 billion and a contingent value right of up to USD 300 million. Chinook is a company that specializes in the development of treatments for IgA nephropathy (IgAN). It is currently in the third phase of development with two late-stage assets: atrasentan and zigakibart. The acquisition is consistent with Novartis' strategy to improve its renal portfolio and address unmet needs in the treatment of severe chronic kidney diseases. It is anticipated that the closure of the transaction will occur in the latter half of 2023. (Source: https://www.novartis.com/news/media-releases/novartis-bolsters-innovative-medicines-strategy-and-renal-pipeline-agreement-acquire-chinook-therapeutics-usd-32bn-upfront-usd-40-share) In June 2024, Dr. Reddy's Laboratories has announced its intention to acquire Haleon's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category, with the exception of the United States. The acquisition encompasses the global NRT brand Nicotinell, as well as its local market-leading brands Nicabate, Habitrol, and Thrive. Dr. Reddy's objective is to strengthen its position in the consumer healthcare sector and to expand its over-the-counter (OTC) business through the acquisition, which is valued at GBP 500 million. Regulatory approvals are anticipated to be obtained prior to the transaction's completion in early Q4 2024. (Source: https://www.drreddys.com/cms/cms/sites/default/files/2024-06/Press%20release%20-%20Dr.%20Reddy%27s%20to%20acquire%20Nicotinell%20consumer%20healthcare.pdf)
Top Companies Market Share in Losartan Industry: (In no particular order of Rank)
- Merck & Co.
- Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Limited
- Aurobindo Pharma Ltd
- Torrent Pharmaceuticals Limited
- Lupin Limited
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of the Losartan Market
Which Region Dominates the Losartan Market in 2024?
According to Cognitive Market Research, North America currently dominates the Losartans market, and the region is expected to have significant growth during the projected period. Hypertension is a prevalent health concern in the region, which has a sizable elderly population. The demand for these medications is robust due to the increased awareness of cardiovascular health and the availability of healthcare services.
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Losartan Potassium API market is anticipated to experience significant growth in the Asia Pacific region as a result of the region's large population and the increasing prevalence of cardiovascular disorders and high blood pressure.
The current report Scope analyzes Losartan Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Losartan Market Share (%) by Region (2021-2033)
Losartan Market Share (%) by Country
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Losartan
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 650.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
- According to Cognitive Market Research, the US had a major share in the Losartan market with a market size of USD 513.01 million in 2024 and is anticipated to grow at a CAGR of 2.5% during the projected period. The U.S. market's Increasing incidence of cardiovascular diseases and hypertension.
- The Canada Losartan market had a market share of USD 78.02 million in 2024 and is anticipated to grow at a CAGR of 3.5% during the projected period. Canada’s Increasing geriatric population and hypertension.
- The Mexico Losartan market is anticipated to see growth at a CAGR of 3.2% during the projected period, with a market size of USD 59.17 million in 2024.
Europe Losartan
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 487.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031.
- The United Kingdom Losartan market had a market share of USD 81.93 million in 2024 and is anticipated to grow at a CAGR of 3.8% during the projected period. In the UK, Losartan sales see an upswing due to the Increasing demand for hypertension treatments.
- The France Losartan market is anticipated to see growth at a CAGR of 2.2% during the projected period, with a market size of USD 44.86 million in 2024.
- According to Cognitive Market Research, the German Losartan market size was valued at USD 96.55 million in 2024 and is anticipated to grow at a CAGR of 3.2% during the projected period. In Germany, Losartan surged due to the significant healthcare infrastructure and an aging population.
- The Italy Losartan market is anticipated to see growth at a CAGR of 2.4% during the projected period, with a market size of USD 41.94 million in 2024.
- The Russia Losartan market is anticipated to see growth at a CAGR of 2.0% during the projected period, with a market size of USD 75.59 million in 2024.
- The Spain Losartan market is anticipated to see growth at a CAGR of 2.1% during the projected period with a market size of USD 39.99 million in 2024
- The Luxembourg Losartan market is anticipated to see growth at a CAGR of 3.1% during the projected period, with a market size of USD 15.12 million in 2024.
- The Portugal Losartan market is anticipated to see growth at a CAGR of 2.8% during the projected period, with a market size of USD 10.24 million in 2024.
- The Greece Losartan market is anticipated to see growth at a CAGR of 3.3% during the projected period, with a market size of USD 5.85 million in 2024.
- The Rest of Europe's Losartan market is anticipated to see growth at a CAGR of 1.7% during the projected period, with a market size of USD 75.59 million in 2024.
Asia Pacific Losartan
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 373.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
- According to Cognitive Market Research, the China Losartan market size was valued at USD 168.24 million in 2024 and is anticipated to grow at a CAGR of 6.0% during the projected period. Losartan surged in China due to raising awareness and improving the treatment of hypertension.
- The Japan Losartan market is anticipated to see growth at a CAGR of 5.0% during the projected period, with a market size of USD 51.59 million in 2024.
- The India Losartan market had a market share of USD 44.86 million in 2024 and is anticipated to grow at a CAGR of 8.3% during the projected period. India's increasing prevalence of hypertension and the expansion of healthcare infrastructure.
- The South Korean Losartan market is anticipated to see growth at a CAGR of 5.6% during the projected period, with a market size of USD 37.39 million in 2024.
- The Australian Losartan market is anticipated to see growth at a CAGR of 6.2% during the projected period, with a market size of USD 19.44 million in 2024.
- The South East Asia Losartan market is anticipated to see growth at a CAGR of 7.5% during the projected period, with a market size of USD 25.80 million in 2024.
- The Rest of Asia Pacific Losartan market is anticipated to see growth at a CAGR of 6.3% during the projected period, with a market size of USD 26.54 million in 2024.
South America Losartan
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 81.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
- According to Cognitive Market Research, the Brazil Losartan market size was valued at USD 34.79 million in 2024 and is anticipated to grow at a CAGR of 4.5% during the projected period. Losartan flourished in Brazil due to increasing incidence of cardiovascular diseases and hypertension.
- Argentina's Losartan market had a market share of USD 13.65 million in 2024 and is anticipated to grow at a CAGR of 4.8% during the projected period. Argentina's Increasing geriatric population and an increased prevalence of hypertension.
- Colombia Losartan market is anticipated to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 7.23 million in 2024.
- Peru Losartan market is anticipated to see growth at a CAGR of 4.1% during the projected period, with a market size of USD 6.66 million in 2024.
- Chile Losartan market is anticipated to see growth at a CAGR of 4.2% during the projected period, with a market size of USD 5.85 million in 2024.
- The Rest of Latin America's Losartan market is anticipated to see growth at a CAGR of 3.0% during the projected period, with a market size of USD 13.09 million in 2024.
Middle East Losartan
According to Cognitive Market Research, the global Losartan market size was estimated at USD 1625.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 32.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031..
- The GCC Countries Losartan market is anticipated to see growth at a CAGR of 5.0% during the projected period, with a market size of USD 13.91 million in 2024. Losartan sales flourish due to the Increasing awareness and education regarding hypertension treatments.
- The Egypt Losartan market is anticipated to see growth at a CAGR of 4.5% during the projected period, with a market size of USD 3.41 million in 2024.
- The South Africa Losartan market is anticipated to see growth at a CAGR of 5.2% during the projected period, with a market size of USD 5.14 million in 2024. Losartan sales flourished in South Africa due to Enhanced healthcare infrastructure and an increase in the demand for hypertension medication.
- The Turkey Losartan market is anticipated to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 2.80 million in 2024.
- The Nigeria Losartan market is anticipated to see growth at a CAGR of 3.3% during the projected period, with a market size of USD 3.41 million in 2024.
- The Rest of the MEA Losartan market is anticipated to see growth at a CAGR of 3.2% during the projected period, with a market size of USD 3.84 million in 2024.
Losartan Market Analysis
Global Losartan Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Losartan Industry growth. Losartan market has been segmented with the help of its Dosage Form, Application Distribution Channel, and others. Losartan market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Losartan Market Dosage Form Segment Analysis
According to Cognitive Market Research, tablets are likely to dominate the Losartan Market over the forecast period owing to the fact that it is simple to administer and guarantee patient compliance.
Powder is the fastest-growing segment in the Losartan Market due to the fact that it may be administered in a variety of dose forms and can be combined with other therapeutic agents or solutions.
Losartan Market Share (%) by Dosage Form in 2021-2033
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Losartan Industry. Request a Free Sample PDF!
Losartan Market Application Segment Analysis
According to Cognitive Market Research, the Hypertension segment holds the largest share of the market. The Losartan market is dominated by hypertension, which is the primary condition for which Losartan is prescribed. An angiotensin II receptor blocker (ARB), losartan is a critical medication for the management of hypertension due to its ability to reduce blood pressure effectively. The demand for Losartan is driven by the high prevalence of hypertension worldwide, resulting in its dominant position in the market.
In the Losartan Market, Diabetic Nephropathy has been expanding at a rapid pace. The Losartan market's fastest-growing category is Diabetic Nephropathy, which is associated with the rising prevalence of diabetes and the risk of renal complications. Losartan is prescribed to safeguard renal function in diabetic patients, leading to an increase in demand for this application among healthcare providers who are seeking effective treatments to prevent and manage kidney harm in this demographic.
Losartan Market Share (%) by Application in 2021-2033
2021
2025
2033
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Losartan Distribution Channel Segment Analysis
Losartan Market Distribution Channel Segment Analysis
According to Cognitive Market Research, The In-house Manufacturing segment holds the largest market share as a result of the preference of major market participants for complete control over the quality and quantity of the products.
In the Losartan market, the rapidly growing sector is the Contract Manufacturing category. The growth in this category is due to the growing demand for outsourcing manufacturing operations to specialized organizations.
- Contract Manufacturing
- In-house Manufacturing
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Conclusion
- The global Losartan market will expand significantly by 4.50% CAGR between 2024 and 2031.
- Tablet is expected to dominate the Losartan Market over the forecast period owing to the fact that it is simple to administer and guarantee patient compliance.
- The In-house Manufacturing segment has the biggest market share as a result of the preference of major market participants for complete control over the quality and quantity of the products.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Losartan Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Losartan Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Dosage Form | Tablet, Powder, Suspension |
| Application | Hypertension, Stroke, Diabetic Nephropathy, Others |
| Distribution Channel | Contract Manufacturing, In-house Manufacturing, Others |
| List of Competitors | Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Torrent Pharmaceuticals Limited, Lupin Limited |
This chapter will help you gain GLOBAL Market Analysis of Losartan. Further deep in this chapter, you will be able to review Global Losartan Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Losartan Revenue Market Size, Trend Analysis 2021 - 2033
-
1.2 Global Losartan Market Size By Regions 2021 - 2033
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Losartan Revenue Market Size By Region
-
-
1.3 Global Losartan Market Size By Dosage Form 2021 - 2033
-
1.3.1 Tablet Market Size
-
1.3.2 Powder Market Size
-
1.3.3 Suspension Market Size
-
-
1.4 Global Losartan Market Size By Application 2021 - 2033
-
1.4.1 Hypertension Market Size
-
1.4.2 Stroke Market Size
-
1.4.3 Diabetic Nephropathy Market Size
-
1.4.4 Others Market Size
-
-
1.5 Global Losartan Market Size By Distribution Channel 2021 - 2033
-
1.5.1 Contract Manufacturing Market Size
-
1.5.2 In-house Manufacturing Market Size
-
1.5.3 Others Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
1.7.2 Global Market Revenue Split By Dosage Form
-
1.7.3 Global Market Revenue Split By Application
-
1.7.4 Global Market Revenue Split By Distribution Channel
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Losartan. Further deep in this chapter, you will be able to review North America Losartan Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Losartan Market Size 2021 - 2033
-
2.1.1 North America Losartan Market Size By Country 2021 - 2033
-
2.1.2 North America Losartan Market Size by Dosage Form 2021 - 2033
-
2.1.2.1 North America Tablet Market Size
-
2.1.2.2 North America Powder Market Size
-
2.1.2.3 North America Suspension Market Size
-
-
2.1.3 North America Losartan Market Size by Application 2021 - 2033
-
2.1.3.1 North America Hypertension Market Size
-
2.1.3.2 North America Stroke Market Size
-
2.1.3.3 North America Diabetic Nephropathy Market Size
-
2.1.3.4 North America Others Market Size
-
-
2.1.4 North America Losartan Market Size by Distribution Channel 2021 - 2033
-
2.1.4.1 North America Contract Manufacturing Market Size
-
2.1.4.2 North America In-house Manufacturing Market Size
-
2.1.4.3 North America Others Market Size
-
-
-
2.2 United States Market Size 2021 - 2033
-
2.2.1 United States Losartan Market Size by Dosage Form 2021 - 2033
-
2.2.2 United States Losartan Market Size by Application 2021 - 2033
-
2.2.3 United States Losartan Market Size by Distribution Channel 2021 - 2033
-
-
2.3 Canada Market Size 2021 - 2033
-
2.3.1 Canada Losartan Market Size by Dosage Form 2021 - 2033
-
2.3.2 Canada Losartan Market Size by Application 2021 - 2033
-
2.3.3 Canada Losartan Market Size by Distribution Channel 2021 - 2033
-
-
2.4 Mexico Market Size 2021 - 2033
-
2.4.1 Mexico Losartan Market Size by Dosage Form 2021 - 2033
-
2.4.2 Mexico Losartan Market Size by Application 2021 - 2033
-
2.4.3 Mexico Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter will help you gain Europe Market Analysis of Losartan. Further deep in this chapter, you will be able to review Europe Losartan Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Losartan Market Size 2021 - 2033
-
3.1.1 Europe Losartan Market Size By Country 2021 - 2033
-
3.1.2 Europe Losartan Market Size by Dosage Form 2021 - 2033
-
3.1.2.1 Europe Tablet Market Size
-
3.1.2.2 Europe Powder Market Size
-
3.1.2.3 Europe Suspension Market Size
-
-
3.1.3 Europe Losartan Market Size by Application 2021 - 2033
-
3.1.3.1 Europe Hypertension Market Size
-
3.1.3.2 Europe Stroke Market Size
-
3.1.3.3 Europe Diabetic Nephropathy Market Size
-
3.1.3.4 Europe Others Market Size
-
-
3.1.4 Europe Losartan Market Size by Distribution Channel 2021 - 2033
-
3.1.4.1 Europe Contract Manufacturing Market Size
-
3.1.4.2 Europe In-house Manufacturing Market Size
-
3.1.4.3 Europe Others Market Size
-
-
-
3.2 United Kingdom Market Size 2021 - 2033
-
3.2.1 United Kingdom Losartan Market Size by Dosage Form 2021 - 2033
-
3.2.2 United Kingdom Losartan Market Size by Application 2021 - 2033
-
3.2.3 United Kingdom Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.3 France Market Size 2021 - 2033
-
3.3.1 France Losartan Market Size by Dosage Form 2021 - 2033
-
3.3.2 France Losartan Market Size by Application 2021 - 2033
-
3.3.3 France Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.4 Germany Market Size 2021 - 2033
-
3.4.1 Germany Losartan Market Size by Dosage Form 2021 - 2033
-
3.4.2 Germany Losartan Market Size by Application 2021 - 2033
-
3.4.3 Germany Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.5 Italy Market Size 2021 - 2033
-
3.5.1 Italy Losartan Market Size by Dosage Form 2021 - 2033
-
3.5.2 Italy Losartan Market Size by Application 2021 - 2033
-
3.5.3 Italy Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.6 Russia Market Size 2021 - 2033
-
3.6.1 Russia Losartan Market Size by Dosage Form 2021 - 2033
-
3.6.2 Russia Losartan Market Size by Application 2021 - 2033
-
3.6.3 Russia Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.7 Spain Market Size 2021 - 2033
-
3.7.1 Spain Losartan Market Size by Dosage Form 2021 - 2033
-
3.7.2 Spain Losartan Market Size by Application 2021 - 2033
-
3.7.3 Spain Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.8 Sweden Market Size 2021 - 2033
-
3.8.1 Sweden Losartan Market Size by Dosage Form 2021 - 2033
-
3.8.2 Sweden Losartan Market Size by Application 2021 - 2033
-
3.8.3 Sweden Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.9 Denmark Market Size 2021 - 2033
-
3.9.1 Denmark Losartan Market Size by Dosage Form 2021 - 2033
-
3.9.2 Denmark Losartan Market Size by Application 2021 - 2033
-
3.9.3 Denmark Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.10 Switzerland Market Size 2021 - 2033
-
3.10.1 Switzerland Losartan Market Size by Dosage Form 2021 - 2033
-
3.10.2 Switzerland Losartan Market Size by Application 2021 - 2033
-
3.10.3 Switzerland Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.11 Luxembourg Market Size 2021 - 2033
-
3.11.1 Luxembourg Losartan Market Size by Dosage Form 2021 - 2033
-
3.11.2 Luxembourg Losartan Market Size by Application 2021 - 2033
-
3.11.3 Luxembourg Losartan Market Size by Distribution Channel 2021 - 2033
-
-
3.12 Rest of Europe Market Size 2021 - 2033
-
3.12.1 Rest of Europe Losartan Market Size by Dosage Form 2021 - 2033
-
3.12.2 Rest of Europe Losartan Market Size by Application 2021 - 2033
-
3.12.3 Rest of Europe Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter will help you gain Asia Pacific Market Analysis of Losartan. Further deep in this chapter, you will be able to review Asia Pacific Losartan Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Losartan Market Size 2021 - 2033
-
4.1.1 Asia Pacific Losartan Market Size By Country 2021 - 2033
-
4.1.2 Asia Pacific Losartan Market Size by Dosage Form 2021 - 2033
-
4.1.2.1 Asia Pacific Tablet Market Size
-
4.1.2.2 Asia Pacific Powder Market Size
-
4.1.2.3 Asia Pacific Suspension Market Size
-
-
4.1.3 Asia Pacific Losartan Market Size by Application 2021 - 2033
-
4.1.3.1 Asia Pacific Hypertension Market Size
-
4.1.3.2 Asia Pacific Stroke Market Size
-
4.1.3.3 Asia Pacific Diabetic Nephropathy Market Size
-
4.1.3.4 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific Losartan Market Size by Distribution Channel 2021 - 2033
-
4.1.4.1 Asia Pacific Contract Manufacturing Market Size
-
4.1.4.2 Asia Pacific In-house Manufacturing Market Size
-
4.1.4.3 Asia Pacific Others Market Size
-
-
-
4.2 China Losartan Market Size 2021 - 2033
-
4.2.1 China Losartan Market Size by Dosage Form 2021 - 2033
-
4.2.2 China Losartan Market Size by Application 2021 - 2033
-
4.2.3 China Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.3 Japan Losartan Market Size 2021 - 2033
-
4.3.1 Japan Losartan Market Size by Dosage Form 2021 - 2033
-
4.3.2 Japan Losartan Market Size by Application 2021 - 2033
-
4.3.3 Japan Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.4 South Korea Losartan Market Size 2021 - 2033
-
4.4.1 South Korea Losartan Market Size by Dosage Form 2021 - 2033
-
4.4.2 South Korea Losartan Market Size by Application 2021 - 2033
-
4.4.3 South Korea Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.5 India Losartan Market Size 2021 - 2033
-
4.5.1 India Losartan Market Size by Dosage Form 2021 - 2033
-
4.5.2 India Losartan Market Size by Application 2021 - 2033
-
4.5.3 India Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.6 Australia Losartan Market Size 2021 - 2033
-
4.6.1 Australia Losartan Market Size by Dosage Form 2021 - 2033
-
4.6.2 Australia Losartan Market Size by Application 2021 - 2033
-
4.6.3 Australia Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.7 Singapore Losartan Market Size 2021 - 2033
-
4.7.1 Singapore Losartan Market Size by Dosage Form 2021 - 2033
-
4.7.2 Singapore Losartan Market Size by Application 2021 - 2033
-
4.7.3 Singapore Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.8 Taiwan Losartan Market Size 2021 - 2033
-
4.8.1 Taiwan Losartan Market Size by Dosage Form 2021 - 2033
-
4.8.2 Taiwan Losartan Market Size by Application 2021 - 2033
-
4.8.3 Taiwan Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.9 South East Asia Losartan Market Size 2021 - 2033
-
4.9.1 South East Asia Losartan Market Size by Dosage Form 2021 - 2033
-
4.9.2 South East Asia Losartan Market Size by Application 2021 - 2033
-
4.9.3 South East Asia Losartan Market Size by Distribution Channel 2021 - 2033
-
-
4.10 Rest of APAC Losartan Market Size 2021 - 2033
-
4.10.1 Rest of APAC Losartan Market Size by Dosage Form 2021 - 2033
-
4.10.2 Rest of APAC Losartan Market Size by Application 2021 - 2033
-
4.10.3 Rest of APAC Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter will help you gain South America Market Analysis of Losartan. Further deep in this chapter, you will be able to review South America Losartan Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Losartan Market Size 2021 - 2033
-
5.1.1 South America Losartan Market Size By Country 2021 - 2033
-
5.1.2 South America Losartan Market Size by Dosage Form 2021 - 2033
-
5.1.2.1 South America Tablet Market Size
-
5.1.2.2 South America Powder Market Size
-
5.1.2.3 South America Suspension Market Size
-
-
5.1.3 South America Losartan Market Size by Application 2021 - 2033
-
5.1.3.1 South America Hypertension Market Size
-
5.1.3.2 South America Stroke Market Size
-
5.1.3.3 South America Diabetic Nephropathy Market Size
-
5.1.3.4 South America Others Market Size
-
-
5.1.4 South America Losartan Market Size by Distribution Channel 2021 - 2033
-
5.1.4.1 South America Contract Manufacturing Market Size
-
5.1.4.2 South America In-house Manufacturing Market Size
-
5.1.4.3 South America Others Market Size
-
-
-
5.2 Brazil Losartan Market Size 2021 - 2033
-
5.2.1 Brazil Losartan Market Size by Dosage Form 2021 - 2033
-
5.2.2 Brazil Losartan Market Size by Application 2021 - 2033
-
5.2.3 Brazil Losartan Market Size by Distribution Channel 2021 - 2033
-
-
5.3 Argentina Losartan Market Size 2021 - 2033
-
5.3.1 Argentina Losartan Market Size by Dosage Form 2021 - 2033
-
5.3.2 Argentina Losartan Market Size by Application 2021 - 2033
-
5.3.3 Argentina Losartan Market Size by Distribution Channel 2021 - 2033
-
-
5.4 Colombia Losartan Market Size 2021 - 2033
-
5.4.1 Colombia Losartan Market Size by Dosage Form 2021 - 2033
-
5.4.2 Colombia Losartan Market Size by Application 2021 - 2033
-
5.4.3 Colombia Losartan Market Size by Distribution Channel 2021 - 2033
-
-
5.5 Peru Losartan Market Size 2021 - 2033
-
5.5.1 Peru Losartan Market Size by Dosage Form 2021 - 2033
-
5.5.2 Peru Losartan Market Size by Application 2021 - 2033
-
5.5.3 Peru Losartan Market Size by Distribution Channel 2021 - 2033
-
-
5.6 Chile Losartan Market Size 2021 - 2033
-
5.6.1 Chile Losartan Market Size by Dosage Form 2021 - 2033
-
5.6.2 Chile Losartan Market Size by Application 2021 - 2033
-
5.6.3 Chile Losartan Market Size by Distribution Channel 2021 - 2033
-
-
5.7 Rest of South America Losartan Market Size 2021 - 2033
-
5.7.1 Rest of South America Losartan Market Size by Dosage Form 2021 - 2033
-
5.7.2 Rest of South America Losartan Market Size by Application 2021 - 2033
-
5.7.3 Rest of South America Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Losartan. Further deep in this chapter, you will be able to review Middle East Losartan Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
-
6.1 Middle East Losartan Market Size 2021 - 2033
-
6.1.1 Middle East Losartan Market Size By Country 2021 - 2033
-
6.1.2 Middle East Losartan Market Size by Dosage Form 2021 - 2033
-
6.1.2.1 Middle East Tablet Market Size
-
6.1.2.2 Middle East Powder Market Size
-
6.1.2.3 Middle East Suspension Market Size
-
-
6.1.3 Middle East Losartan Market Size by Application 2021 - 2033
-
6.1.3.1 Middle East Hypertension Market Size
-
6.1.3.2 Middle East Stroke Market Size
-
6.1.3.3 Middle East Diabetic Nephropathy Market Size
-
6.1.3.4 Middle East Others Market Size
-
-
6.1.4 Middle East Losartan Market Size by Distribution Channel 2021 - 2033
-
6.1.4.1 Middle East Contract Manufacturing Market Size
-
6.1.4.2 Middle East In-house Manufacturing Market Size
-
6.1.4.3 Middle East Others Market Size
-
-
-
6.2 Saudi Arabia Losartan Market Size 2021 - 2033
-
6.2.1 Saudi Arabia Losartan Market Size by Dosage Form 2021 - 2033
-
6.2.2 Saudi Arabia Losartan Market Size by Application 2021 - 2033
-
6.2.3 Saudi Arabia Losartan Market Size by Distribution Channel 2021 - 2033
-
-
6.3 Turkey Losartan Market Size 2021 - 2033
-
6.3.1 Turkey Losartan Market Size by Dosage Form 2021 - 2033
-
6.3.2 Turkey Losartan Market Size by Application 2021 - 2033
-
6.3.3 Turkey Losartan Market Size by Distribution Channel 2021 - 2033
-
-
6.4 UAE Losartan Market Size 2021 - 2033
-
6.4.1 UAE Losartan Market Size by Dosage Form 2021 - 2033
-
6.4.2 UAE Losartan Market Size by Application 2021 - 2033
-
6.4.3 UAE Losartan Market Size by Distribution Channel 2021 - 2033
-
-
6.5 Egypt Losartan Market Size 2021 - 2033
-
6.5.1 Egypt Losartan Market Size by Dosage Form 2021 - 2033
-
6.5.2 Egypt Losartan Market Size by Application 2021 - 2033
-
6.5.3 Egypt Losartan Market Size by Distribution Channel 2021 - 2033
-
-
6.6 Qatar Losartan Market Size 2021 - 2033
-
6.6.1 Qatar Losartan Market Size by Dosage Form 2021 - 2033
-
6.6.2 Qatar Losartan Market Size by Application 2021 - 2033
-
6.6.3 Qatar Losartan Market Size by Distribution Channel 2021 - 2033
-
-
6.7 Rest of Middle East Losartan Market Size 2021 - 2033
-
6.7.1 Rest of Middle East Losartan Market Size by Dosage Form 2021 - 2033
-
6.7.2 Rest of Middle East Losartan Market Size by Application 2021 - 2033
-
6.7.3 Rest of Middle East Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Losartan. Further deep in this chapter, you will be able to review Middle East Losartan Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
-
7.1 Africa Losartan Market Size 2021 - 2033
-
7.1.1 Africa Losartan Market Size By Country 2021 - 2033
-
7.1.2 Africa Losartan Market Size by Dosage Form 2021 - 2033
-
7.1.2.1 Africa Tablet Market Size
-
7.1.2.2 Africa Powder Market Size
-
7.1.2.3 Africa Suspension Market Size
-
-
7.1.3 Africa Losartan Market Size by Application 2021 - 2033
-
7.1.3.1 Africa Hypertension Market Size
-
7.1.3.2 Africa Stroke Market Size
-
7.1.3.3 Africa Diabetic Nephropathy Market Size
-
7.1.3.4 Africa Others Market Size
-
-
7.1.4 Africa Losartan Market Size by Distribution Channel 2021 - 2033
-
7.1.4.1 Africa Contract Manufacturing Market Size
-
7.1.4.2 Africa In-house Manufacturing Market Size
-
7.1.4.3 Africa Others Market Size
-
-
-
7.2 Nigeria Losartan Market Size 2021 - 2033
-
7.2.1 Nigeria Losartan Market Size by Dosage Form 2021 - 2033
-
7.2.2 Nigeria Losartan Market Size by Application 2021 - 2033
-
7.2.3 Nigeria Losartan Market Size by Distribution Channel 2021 - 2033
-
-
7.3 South Africa Losartan Market Size 2021 - 2033
-
7.3.1 South Africa Losartan Market Size by Dosage Form 2021 - 2033
-
7.3.2 South Africa Losartan Market Size by Application 2021 - 2033
-
7.3.3 South Africa Losartan Market Size by Distribution Channel 2021 - 2033
-
-
7.4 Rest of Africa Losartan Market Size 2021 - 2033
-
7.4.1 Rest of Africa Losartan Market Size by Dosage Form 2021 - 2033
-
7.4.2 Rest of Africa Losartan Market Size by Application 2021 - 2033
-
7.4.3 Rest of Africa Losartan Market Size by Distribution Channel 2021 - 2033
-
This chapter provides an in-depth analysis of the market share among key competitors of Losartan. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2024
-
8.1.2 Global Losartan Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability) Sample Format
-
8.2.1 Merck & Co.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Teva Pharmaceutical Industries Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Dr. Reddy’s Laboratories Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Sun Pharmaceutical Industries Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Aurobindo Pharma Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Torrent Pharmaceuticals Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Lupin Limited
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Impact of Trump's Tariff War on Losartan Market
-
9.1.1 Policy Shifts That Influence the Losartan Market
-
9.1.2 Tariff and their Long-Term Impact on the Losartan Market
-
9.1.3 Trade Wars and Supply Chain Changes in the Losartan Market
-
9.1.4 Regional and Geopolitical implications in the Losartan Market
-
9.1.5 Tax Reforms and Business Expansion in the Losartan Market
-
9.1.6 Investor Sentiment in Key Segments of the Losartan Market
-
9.1.7 Environmental Rollbacks and ESG Implications in the Losartan Market
-
9.1.8 Consumer Behavior and Brand Perception in the Politicized in Losartan Market
-
9.1.9 Strategic takeaways for future administration in Losartan Market
-
-
9.2 Market Drivers
-
9.3 Market Restraints
-
9.4 Market Trends
-
9.5 Market Opportunity
-
9.6 Technological Road Map (Subject to Data Availability)
-
9.7 Product Life Cycle (Subject to Data Availability)
-
9.8 Consumer Preference Analysis
-
9.9 Market Attractiveness Analysis
-
9.10 PESTEL Analysis
-
9.10.1 Political Factors
-
9.10.2 Economic Factors
-
9.10.3 Social Factors
-
9.10.4 Technological Factors
-
9.10.5 Legal Factors
-
9.10.6 Environmental Factors
-
-
9.11 Industrial Chain Analysis (Subject to Data Availability)
-
9.11.1 Industry Chain Analysis
-
9.11.2 Manufacturing Cost Analysis
-
9.11.3 Supply Side Analysis
-
9.11.3.1 Raw Material Analysis
-
9.11.3.2 Raw Material Procurement Analysis
-
9.11.3.3 Raw Material Price Trend Analysis
-
-
-
9.12 Porter’s Five Forces Analysis
-
9.12.1 Bargaining Power of Suppliers
-
9.12.2 Bargaining Power of Buyers
-
9.12.3 Threat of New Entrants
-
9.12.4 Threat of Substitutes
-
9.12.5 Degree of Competition
-
-
9.13 Patent Analysis (Subject to Data Availability)
-
9.14 ESG Analysis
Segmentation Dosage Form Analysis 2019 -2031, will provide market size split by Dosage Form. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Dosage Form Analysis 2021 - 2033
-
10.1 Tablet
-
10.1.1 Global Losartan Revenue Market Size and Share by Tablet 2021 - 2033
-
-
10.2 Powder
-
10.2.1 Global Losartan Revenue Market Size and Share by Powder 2021 - 2033
-
-
10.3 Suspension
-
10.3.1 Global Losartan Revenue Market Size and Share by Suspension 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
-
11.1 Hypertension
-
11.1.1 Global Losartan Revenue Market Size and Share by Hypertension 2021 - 2033
-
-
11.2 Stroke
-
11.2.1 Global Losartan Revenue Market Size and Share by Stroke 2021 - 2033
-
-
11.3 Diabetic Nephropathy
-
11.3.1 Global Losartan Revenue Market Size and Share by Diabetic Nephropathy 2021 - 2033
-
-
11.4 Others
-
11.4.1 Global Losartan Revenue Market Size and Share by Others 2021 - 2033
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Distribution Channel Analysis 2021 - 2033
-
12.1 Contract Manufacturing
-
12.1.1 Global Losartan Revenue Market Size and Share by Contract Manufacturing 2021 - 2033
-
-
12.2 In-house Manufacturing
-
12.2.1 Global Losartan Revenue Market Size and Share by In-house Manufacturing 2021 - 2033
-
-
12.3 Others
-
12.3.1 Global Losartan Revenue Market Size and Share by Others 2021 - 2033
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Losartan market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Chapter 14 Research Methodology and Sources
-
14.1 Primary Data Collection
-
14.1.1 Steps for Primary Data Collection
-
14.1.1.1 Identification of KOL
-
-
14.1.2 Backward Integration
-
14.1.3 Forward Integration
-
14.1.4 How Primary Research Help Us
-
14.1.5 Modes of Primary Research
-
-
14.2 Secondary Research
-
14.2.1 How Secondary Research Help Us
-
14.2.2 Sources of Secondary Research
-
-
14.3 Data Validation
-
14.3.1 Data Triangulation
-
14.3.2 Top Down & Bottom Up Approach
-
14.3.3 Cross check KOL Responses with Secondary Data
-
-
14.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1 Data Gathering
- 1.1 Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.1.1.1 Identification of KOL
- 1.1.1.2 Backward Integration
- 1.1.1.3 Forward Integration
- 1.1.1.4 How Primary Research Help Us
- 1.1.1.5 Modes of Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.2 Secondary Research
- 1.2.1 How Secondary Research Help Us
- 1.2.2 Sources of Secondary Research
- 1.1 Primary Research
- 2 Data Validation
- 2.1 Cross check KOL Responses with Secondary Data
- 2.2 Top Down & Bottom Up Approach
- 2.3 Data Triangulation
- 3 Data Representation
Key Questions Answered By Losartan Market Report 2025
| Why Tablet have a significant impact on Losartan market? |
| What are the key factors affecting the Tablet and Powder of Losartan Market? |
| What is the CAGR/Growth Rate of Hypertension during the forecast period? |
| By type, which segment accounted for largest share of the global Losartan Market? |
| Which region is expected to dominate the global Losartan Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
